Skip to main content
Clinical Trials/NCT01477450
NCT01477450CompletedNot Applicable

Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects

University of Cincinnati1 site in 1 country30 target enrollmentStarted: October 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
1
Primary Endpoint
Return of Oxygen Saturation to Baseline (Sea Level) Values

Study Overview

Brief Summary

This study will compare the ability of pulsed-dose oxygen from a concentrator to reverse altitude-induced hypoxemia compared to compressed gas from a standard oxygen cylinder.

Detailed Description

Subjects will be monitored non-invasively with pulse oximetry, end-tidal carbon dioxide, tissue oxygenation and ECG. The mean seal level oxygen saturation will be recorded.Subjects exposed to an altitude of 14,000 feet will experience moderate hypobaric hypoxia. The mean oxygen saturation at this altitude is 83%. Subjects will receive oxygen from both an oxygen concentrator or a cylinder of oxygen following exposure to hypobarism. Oxygen from each source will be increased in 1 liter per minute increments until the oxygen saturation returns to the baseline sea level oxygen saturation.

The oxygen requirement to return oxygen saturation to baseline values will be recorded. The flow from the concentrator and the cylinder will be compared.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Current altitude chamber certification
  • •Age 18 years - 60 years

Exclusion Criteria

  • •Current upper respiratory infection
  • •Current symptoms of lower respiratory infection -- productive cough

Arms & Interventions

1 L/min ; 16 mL

Active Comparator

Cylinder oxygen delivery (1 L/min) followed by pulse-dose oxygen by concentrator (16 mL)

Intervention: Pulse-dose oxygen (Device)

1 L/min ; 16 mL

Active Comparator

Cylinder oxygen delivery (1 L/min) followed by pulse-dose oxygen by concentrator (16 mL)

Intervention: Cylinder oxygen delivery (Device)

2 L/min ; 32 mL

Active Comparator

Cylinder oxygen delivery (2 L/min) followed by pulse-dose oxygen by concentrator (32 mL)

Intervention: Pulse-dose oxygen (Device)

2 L/min ; 32 mL

Active Comparator

Cylinder oxygen delivery (2 L/min) followed by pulse-dose oxygen by concentrator (32 mL)

Intervention: Cylinder oxygen delivery (Device)

3 L/min ; 48 mL

Active Comparator

Cylinder oxygen delivery (3 L/min) followed by pulse-dose oxygen by concentrator (48 mL)

Intervention: Pulse-dose oxygen (Device)

3 L/min ; 48 mL

Active Comparator

Cylinder oxygen delivery (3 L/min) followed by pulse-dose oxygen by concentrator (48 mL)

Intervention: Cylinder oxygen delivery (Device)

Outcomes

Primary Outcomes

Return of Oxygen Saturation to Baseline (Sea Level) Values

Time Frame: 50 minutes

Oxygen will be titrated from either an oxygen concentrator or an oxygen cylinder in liters per minute until the oxygen saturation returns to the sea level value. The flow in liters per minute is the dependent variables. Each participant will experience induced hypoxemia followed by cylinder oxygen delivery; each will also experience induced hypoxemia followed by pulse-dose oxygen from a concentrator.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Rich Branson, M.D.

Clinical Professor

University of Cincinnati

Study Sites (1)

Loading locations...

Similar Trials